1 / 9

Cancer Gene Therapy Market to grow at 20.7% CAGR from 2016 to 2024

Get more details @ http://bit.ly/2dDsO02 <br>Companies operating in carcinoembryonic antigen market includes Abbott Diagnostics, Roche Diagnostics, Quest Diagnostics and GenWay Biotech. Companies operating in this industry are focusing on strategies such as mergers and acquisitions to maintain leadership position.

jueekate
Download Presentation

Cancer Gene Therapy Market to grow at 20.7% CAGR from 2016 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Cancer Gene Therapy Market share to grow at 20.7% CAGR from 2016 to 2024: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from Cancer Gene Therapy Market: • Global Market Insights, Inc., says Cancer gene therapy industry revenue, which was assessed at USD 805.5 million in 2015, is projected to hit USD 4.3 billion by 2024. • A significant rise in the number of cancer incidences has led to the deployment of genome technologies, which will spur Cancer Gene Therapy Market size. • Heavy funding by the government for cancer research programs and beneficial schemes favoring cancer screening programs are expected to produce lucrative avenues for cancer gene therapy market. • Considering the regional trends, cancer gene therapy industry in China, which accounted for 35% of Asia Pacific cancer gene therapy market share in 2015, is projected to record a CAGR of 21% over the next few years, having collected a revenue of USD 99.6 million in 2015. • Cancer gene therapy market in Japan, worth USD 78.2 million in 2015, is projected to expand at a CAGR of 20.9% over the period from 2016 to 2024.

  3. Continued... • UK cancer gene therapy industry, which was assessed at USD 92 million in 2015, is set to grow at an annual rate of 20.8% over the coming seven years, subject to high frequency of cancer among the nations’ population along with the acceptance of modern treatment methodologies. • U.S. cancer gene therapy industry, which contributed more than 95% of North America cancer gene therapy market revenue in 2015, is projected to grow at a rate of 20.9% over the coming seven years. • Cancer gene therapies comprise gene transfer, oncolytic virotherapy, and gene induced immunotherapy. • NewLink Genetics Corporation, ZIOPHARM Oncology Incorporation, Shenzhen SibionoGeneTech Company Limited, Genelux Corporation, Gradalis Incorporation, Altor Bioscience Corporation, Shanghai Sunway Biotech Company Limited, Amgenen Incorporation, MultiVir Incorporation, Aduro Biotech Incorporation, OncoGeneX Pharmaceuticals Company, GlobeImmune Incorporation, MolMed S.p.A., and BioCancell Therapeutic Incorporation are the few of the established players of cancer gene therapy industry.

  4. U.S. Cancer Gene Therapy Market size, by type, 2012 - 2024 (USD Million)

  5. Browse Full Market Research Report On Cancer Gene Therapy Market @ http://bit.ly/2cXsFFD Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/763https://www.gminsights.com/request-sample/detail/49

  6. Table of Content: • Chapter 1. Methodology and Scope • 1.1. Research Methodology • 1.1.1. Initial data exploration • 1.1.2. Statistical modeling and forecast • 1.1.3. Industry insights and validation • 1.1.4. Research scope & assumptions • 1.2. Data Sources • Chapter 2. Executive Summary • 2.1. Cancer genetics industry 3600 synopsis, 2012 - 2024 • 2.1.1. Business trends • 2.1.2. Regional trends • 2.1.3. Application trends • Chapter 3. Cancer Gene Therapy Industry Insights • 3.1. Industry segmentation

  7. Table of Content: • 3.2. IIndustry Size and forecast, 2012 - 2024 • 3.3. Industry Impact forces • 3.3.1. Growth drivers • 3.3.1.1. Technological advancements • 3.3.1.2. Increased adoption of nanotechnology • 3.3.1.3. Favorable government regulations • 3.3.2. Industry pitfalls & challenges • 3.3.2.1. High cost of cancer genetherapy • 3.4. Growth potential analysis • 3.5. Porter’s analysis • 3.6. Key opportunities prioritized, 2015 • 3.7. PESTEL analysis • 3.8. Regulatory Landscape • 3.8.1. U.S. • 3.8.2. EU • 3.8.3. China

  8. Table of Content: • 3.9. Scientific and Ethical issues in Gene Therapy • 3.10. Competitive landscape, 2015 • 3.11. Pipeline Analysis by cancer type • 3.11.1. Head and Neck Cancer Pipeline Analysis • 3.11.2. Breast Cancer Pipeline Analysis • 3.11.3. Gastro Intestinal Cancer Pipeline Analysis • 3.11.4. Gentiourinary Cancer Pipeline Analysis • 3.11.5. Gynecological Cancer Pipeline Analysis • 3.11.6. Haemotological Cancer Pipeline Analysis • 3.11.7. Neurologic Cancer Pipeline Analysis • 3.11.8. Respiratory Cancer Pipeline Analysis • 3.11.9. Skin Cancer Pipeline Analysis

  9. Stay In Touch Website: www.gminsights.com Social Media:

More Related